Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 8, No 6 (2012) THE EFFECT OF MAGNESIUM DRUGS ON THE PHYSICAL PERFORMANCE OF YOUNG PEOPLE WITH MITRAL VALVE PROLAPSE: RESULTS OF NONCOMPARATIVE STUDY Abstract  similar documents
K. M. Dzeranova, A. G. Avtandilov, N. V. Vertkina
"... Aim. To study the dynamics of physical performance in young people with mitral valve prolapse (MVP ..."
 
Vol 9, No 4 (2013) EFFECT OF MAGNESIUM OROTATE ON CONNECTIVE TISSUE MATRIX AND CARDIAC INOTROPIC FUNCTION IN PATIENTS WITH MITRAL VALVE PROLAPSE. CLINICAL AND MORPHOLOGICAL STUDY Abstract  similar documents
A. G. Avtandilov, K. M. Dzeranova, T. G. Borovaya, L. V. Didenko
"... contractility in patients with mitral valve prolapse before and after magnesium orotate course. Material ..."
 
Vol 3, No 3 (2007) COMPARATIVE EFFECTS OF MONOTHERAPY WITH MAGNESIUM AND COMBINED THERAPY WITH MAGNESIUM AND Β-BLOCKER ON PRIMARY MITRAL VALVE PROLAPSE WITH HEART RHYTHM DISORDERS Abstract  similar documents
E. G. Nurtdinova, A. N. Zakirova, T. B. Khairetdinova
"... -blocker on primary mitral valve prolapse (MVP) with heart rhythm disorders. Material and methods. 71 ..."
 
Vol 6, No 5 (2010) MAGNESIUM AND MITRAL VALVE PROLAPSE. EFFICACY AND THE POINTS OF APPLICATION Abstract  similar documents
A. G. Avtandilov, K. M. Dzeranova, A. A. Pukhaeva, E. D. Manizer
"... Mitral valve prolapse (MVP) is a manifestation of the hereditary syndrome of differentiated ..."
 
Vol 10, No 1 (2014) MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES: TIME TO ACT Abstract  similar documents
E. I. Trisvetova
"... of magnesium deficiency is realized using magnesium-containing drugs, for example magnesium orotate, having ..."
 
Vol 8, No 4 (2012) MAGNESIUM IN CLINICAL PRACTICE Abstract  similar documents
E. L. Trisvetova
"... the effectiveness of magnesium orotate for many cardiovascular diseases. ..."
 
Vol 4, No 5 (2008) MOLECULAR MECHANISMS OF ACTION OF MAGNESIUM OROTATE ON CARDIOVASCULAR SYSTEM Abstract  similar documents
I. Yu. Torshin, O. A. Gromova
"... of orotic acid and magnesium orotate on cardiovascular system as well as therapeutic implementation ..."
 
Vol 11, No 2 (2015) MORPHOFUNCTIONAL CHARACTERISTICS OF FIBROBLASTS (MCCOY CELL LINE) CULTURED WITH MAGNESIUM PREPARATIONS Abstract  similar documents
L. V. Didenko, T. G. Borovaya, E. A. Kost, E. A. Ulubieva, A. V. Timofeeva, A. G. Avtandilov
"... Aim. To study the effect of magnesium orotate, magnesium/pyridoxine combination and magnesium ..."
 
Vol 13, No 1 (2017) CHANGE IN CONTENT OF GLYCOPROTEINS ON THE SURFACE OF ENDOTHELIAL CELL CULTURE EA.HY 926 AND INTIMA OF INTERNAL CAROTID ARTERIES UNDER THE INFLUENCE OF MAGNESIUM OROTATE Abstract  similar documents
L. V. Didenko, E. A. Ulubieva, T. G. Borovaya, A. G. Avtandilov, N. V. Shevlyagina, V. G. Zhukhovitsky, O. M. Grinkevich, M. V. Mezentseva
"... the influence of magnesium orotate. Material and methods. Endotheliocytes of cell culture EA.hy 926 were ..."
 
Vol 12, No 1 (2016) Effect of magnesium on the cardiovascular system in women Abstract  PDF (Eng)  similar documents
E. A. Ulubieva, A. G. Avtandilov
"... Обобщены современные научные данные последних лет о влиянии магния на сердечно-сосудистую ..."
 
Vol 7, No 4 (2011) FOCUS ON MAGNESIUM BASED DRUGS Abstract  similar documents
I. I. Esenova
"... В современном мире недостаток магния в организме является одним из наиболее часто встречающихся ..."
 
Vol 8, No 3 (2012) MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES Abstract  similar documents
A. V. Govorin, A. P. Filev
"... эффективность препаратов магния при различных патологических состояниях системы кровообращения. Физиологическое ..."
 
Vol 5, No 5 (2009) EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Y. Bart, M. P. Mikhaylusova, B. N. Mamtsev
"... in patients with functional mitral regurgitation (MR) of various degrees. Material and methods. A total ..."
 
Vol 6, No 4 (2010) DIAGNOSTICS AND TREATMENT OF MITRAL VALVE PROLAPSE Abstract  similar documents
D. A. Kuzhel, G. V. Matyushin, E. A. Savchenko
"... The mitral valve prolapse (MVP) is one of the most inconsistent diagnose. In the most cases ..."
 
Vol 5, No 1 (2009) ECHOCARDIOGRAPHIC AND LABORATORY MARKERS OF CHRONIC HEART FAILURE: WHETHER IT IS POSSIBLE TO USE THEM IN RHEUMATIC MITRAL DISEASES? Abstract  similar documents
T. A. Kazakovtseva, N. A. Shostak
"... ) natriuretic peptides, in patients with mitral heart diseases of rheumatic aetiology. Material and methods ..."
 
Vol 7, No 4 (2011) CLINICAL IMPORTANCE OF IDIOPATHIC MITRAL ANNULAR CALCIFICATION Abstract  similar documents
N. S. Chipigina, G. M. Urvacheva, N. A. Shostak
"... Idiopathic mitral annular calcification (MAC) — pathological states that diagnosed mostly often ..."
 
Vol 7, No 6 (2011) MITRAL ANNULAR CALCIFICATION IN ELDERLY PATIENTS. CLINICAL AND ECHOCARDIOGRAPHIC CHARACTERISTICS Abstract  similar documents
N. S. Chipigina, G. M. Urvacheva, N. A. Shostak, I. V. Zhitareva, I. Yu. Zhitomirskaya
"... Background. The clinical significance of idiopathic mitral annular calcification (MAC) often ..."
 
Vol 4, No 1 (2008) TISSUE DOPPLEROGRAPHY IN EARLY DIAGNOSIS OF FUNCTIONAL MYOCARDIAL DISORDERS IN ARTERIAL HYPERTENSION Abstract  similar documents
Y. A. Vasyuk, A. B. Hadzegova, S. V. Ivanova, E. N. Yuschuk, I. M. Amirbegishvili, N. I. Gerasimova
"... - and Doppler-echocardiography of transmitral blood flow, TDG of mitral annulus, determination of blood level ..."
 
Vol 15, No 5 (2019) The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 1) Abstract  similar documents
A. S. Safaryan, V. S. Sargsyan, T. V. Kamyshova, N. M. Akhmedzhanov, D. V. Nebieridze, E. A. Poddubskaya
"... Статья посвящена влиянию магния на гомеостаз организма и, в частности, на сердечно-сосудистую ..."
 
Vol 16, No 3 (2020) The Role of Magnesium in the Development of Cardiovascular Diseases and the Possibility of their Prevention and Correction with Magnesium Preparations (Part 2) Abstract  similar documents
A. S. Safaryan, V. S. Sargsyan, D. V. Nebieridze
"... Статья посвящена влиянию магния на гомеостаз организма и, в частности, на сердечно-сосудистую ..."
 
Vol 6, No 5 (2010) POTASSIUM AND MAGNESIUM DRUGS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN THE PRACTICE OF PRIMARY CARE PHYSICIAN Abstract  similar documents
A. M. Shilov, M. V. Melnik, A. O. Osiya, A. S. Lishuta
"... Обсуждается роль дефицита магния и калия в развитии сердечно-сосудистых заболеваний и их ..."
 
Vol 15, No 6 (2019) Study of the Effect of Proton Pump Inhibitors on the Development of Hypomagnesemia in Patients with Paroxysmal Atrial Fibrillation on the Background of Autonomic Sinus Node Dysfunction Abstract  similar documents
Ya. G. Bozhko, M. V. Arkhipov, N. A. Belokonova
"... .51 [0.45-0.59] mmol/l vs 0.48 [0.44-0.51] mmol/l, p=0.04). To substantiate the observed effects ..."
 
Vol 3, No 5 (2007) TISSUE DOPPLER IMAGING OF LONGITUDINAL MOVEMENT OF A FIBROUS RING OF MITRAL VALVE DURING ISOVOLUMIC PERIODS IN LEFT VENTRICULAR HYPERTROPHY Abstract  similar documents
B. Amarjagal, S. B. Tkachenko, N. A. Mazur, N. F. Beresten
"... of mitral valve (MFR) during isovolumic contraction (IVC) and relaxation (IVR) in hypertensive patients ..."
 
Vol 6, No 4 (2010) MAGNESIUM METABOLISM AND CLINICAL CHARACTERISTICS OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
A. V. Yezhov, L. T. Pimenov, M. A. Makarova, T. V. Savelyev
"... обмена магния у больных ишемической болезнью сердца (ИБС). Материал и методы. В исследование включены ..."
 
Vol 9, No 1 (2013) FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Ya. Bart, E. A. Vartanyan
"... .001), III-IV degree mitral regurgitation (p=0.007), hyperuricemia (p<0.001), lower exercise tolerance (p=0 ..."
 
Vol 8, No 2 (2012) ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS Abstract  similar documents
A. V. Govorin, A. P. Filev
"... безопасности различных лекарственных форм АСК. Гидроокись магния, входящая в комбинированный препарат ..."
 
Vol 6, No 3 (2010) IS THERE AN ALTERNATIVE TO EJECTION FRACTION IN INSTRUMENTAL EVALUATION OF CHRONIC HEART FAILURE SEVERITY IN POST-MYOCARDIAL INFARCTION PATIENTS? Abstract  similar documents
T. A. Kazakovtseva, N. A. Shostak
"... of LV isovolumic contraction and relaxation, Е/А ratio for mitral flow, grade of valvular regurgitation ..."
 
Vol 9, No 4 (2013) EFFECTS OF TRIMETAZIDINE ON THE TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE Abstract  similar documents
Yu. N. Fedulaev, N. S. Pavlyuchenko, T. V. Pinchuk, S. Kh. Galachieva, A. A. Kozina, V. N. Ryzhenkov
"... only standard therapy. Echocardiographic parameters, including mitral Doppler flow indices were ..."
 
Vol 16, No 1 (2020) Decrease in Efficacy of Warfarin as a Result of Drug-Drug Interaction (Case Report) Abstract  similar documents
N. T. Vatutin, G. G. Taradin, G. A. Ignatenko, E. S. Gasendich, A. V. Harchenko, I. B. Povaljaeva
"... in the efficacy of warfarin in a patient with mitral stenosis while taking a combined choleretic drug is presented ..."
 
Vol 10, No 3 (2014) EFFECT OF ANTIVIRAL THERAPY ON HEART AND LIVER HEMODYNAMICS IN PATIENTS WITH VIRAL CIRRHOSIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... velocity at the fibrous ring of the mitral valve (p<0.001). The correlation between systolic velocity ..."
 
Vol 6, No 6 (2010) NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION Abstract  similar documents
E. M. Khurs, A. V. Poddubnaya, M. G. Evsina, E. M. Futerman, O. G. Smolenskaya
"... in group A1 with type 2 and type 3 of LV remodeling reduced less (2%, p=0.02 and 4%, p=0.04, respectively ..."
 
Vol 6, No 3 (2010) THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, Ju. N. Rodionova, E. K. Panferova
"... , respectively, р=0,03). Negative relations between aldosterone and estradiol levels (r=-0,3; p=0,04 ..."
 
Vol 7, No 1 (2011) RESPIRATORY FUNCTION IN PATIENTS WITH RHEUMATIC HEART DISEASE COMPLICATED WITH PULMONARY HYPERTENSION Abstract  similar documents
N. A. Shostak, A. A. Klimenko, I. A. Novikov
"... . Patients (n=56; 4 men and 52 women; aged 63,25±7,93) with rheumatic combined mitral and aortic valvular ..."
 
Vol 12, No 5 (2016) Hypertrophic Cardiomyopathy and Connective Tissue Dysplasia Syndrome: Comorbidity Variants Abstract  similar documents
Yu. N. Belenkov, E. V. Privalova, V. Yu. Kaplunova, I. S. Chekneva, Yu. I. Najmann, M. V. Kozhevnikova, G. A. Shakaryants, A. S. Lishuta
"... was found in 17% of patients (mitral valve prolapse – 6.3%, tricuspid valve prolapse – 2.7%, supplemental ..."
 
Vol 15, No 2 (2019) Remodeling of the Pulmonary Circulation in Patients with Viral Liver Cirrhosis Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko
"... of the mitral valve in comparison with the reference level was found in 21 (36%) VLC patients with ascites ..."
 
Vol 14, No 6 (2018) Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety Abstract  PDF (Eng)  similar documents
N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov
"... safety criteria is [0,02-0,38] for QT prolongation and [-0,04-0,04] for bradycardia. Conclusion. Safety ..."
 
Vol 7, No 3 (2011) EFFECT OF THERAPEUTIC TRAINING AND ACTIVE OUTPATIENT MANAGEMENT ON CLINICAL STATE AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE (THREE YEAR FOLLOW-UP) Abstract  similar documents
A. P. Rebrov, N. A. Kosheleva
"... conventionally managed. Kaplan-Meier curves revealed that risk of CHF decompensation (р=0.001), mortality (р=0.04 ..."
 
Vol 12, No 3 (2016) ESTIMATION OF RIGHT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE IN DIFFERENT AGE GROUPS Abstract  PDF (Eng)  similar documents
R. A. Gajfulin, A. N. Sumin, O. G. Arhipov
"... correlated with age: At (p=0.004); Et/At (p=0.001); Vpt (p=0.002) and e't/a't ratio (p=0.004). Conclusion ..."
 
Vol 16, No 3 (2020) The Short-Term Effect of Stent Size and Number on Left Ventricular Systolic Function Improvement After Elective Percutaneous Coronary Intervention Abstract  PDF (Eng)  similar documents
Sh. Mostafa, O. Sanad, M. Shawky, M. Magdy, E. Elkeshk
"... (p=0.001), and a number of stents (p=0.04). There was strong negative correlation between stent ..."
 
Vol 13, No 5 (2017) LEFT ATRIAL FUNCTION: MODERN ASSESSMENT METHODS AND CLINICAL SIGNIFICANCE Abstract  similar documents
E. N. Pavlyukova, D. A. Kuzhel, G. V. Matyushin
"... , thus without mitral valve disease LA expanding is a sign of LV filling pressure augmentation ..."
 
Vol 11, No 3 (2015) IMPACT OF THE ANTIVIRAL THERAPY ON CARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Goncharova, E. V. Radaeva
"... at fibrous ring of mitral valve and high viral load. Strong correlation (r=0.81; p<0.05) was also found ..."
 
Vol 5, No 3 (2009) EFFICACY OF IVABRADINE AND VERAPAMIL IN PATIENTS WITH DIASTOLIC HEART FAILURE CAUSED BY LEFT VENTRICLE IMPAIRED RELAXATION Abstract  similar documents
K. G. Adamyan, A. L. Chilingarian
"... additional differences appeared (midwall fractional shortening; E/Em of lateral mitral annulus – 8,6±4 ..."
 
Vol 15, No 1 (2019) Assessment of Antithrombotic Therapy in Patients with Atrial Fibrillation for 2015-2017 According to the Registry of the Clinic of the Scientific Research Institute of Medical Problems of the North of Krasnoyarsk City Abstract  similar documents
A. A. Tuchkov, N. G. Gogolashvili, R. A. Yaskevich
"... , mitral stenosis. The diagnosis of AF was established in accordance with the current recommendations. All ..."
 
Vol 15, No 4 (2019) Atrial Septal Aneurysm in Adult Patients of Therapeutic Hospital Abstract  similar documents
O. V. Ryazantseva, N. I. Lenkova, O. D. Ostroumova, E. V. Shikh, S. M. Rykova
"... ). Undifferentiated connective tissue dysplasia was diagnosed in 14 (93.3%) ASA patients. Prolapse of mitral (60 ..."
 
Vol 12, No 6 (2016) EFFECT OF ANTIVIRAL THERAPY ON CARDIOHEMODYNAMIC INDICATORS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS AND LIVER CIRRHOSIS Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, E. V. Radaeva
"... negative peak (Em) in the mitral valve fibrous ring and increased viral load (r=0.31; p<0.05), as well ..."
 
Vol 16, No 1 (2020) Control Of Anticoagulation Therapy in Atrial Fibrillation (COAT-AF Study) in Real Clinical Practice Abstract  similar documents
A. A. Zarudsky, A. A. Gavrilova, Т. S. Filinichenko
"... of 62.55±11.12 years. Exclusion criteria were mitral stenosis, mechanic prosthetic valve, first episode ..."
 
Vol 4, No 1 (2008) COMPARISON OF ACE INHIBITOR (FOSINOPRIL) AND Β-ADRENOBLOCKER (ATENOLOL) EFFECTS ON AUTONOMIC REGULATION OF THE HEART IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
A. R. Kiselyov, V. I. Gridnev, O. V. Shevchenko, O. M. Posnenkova, A. N. Strunina, V. A. Schwarz, Ja. P. Dovgalevsky
"... ) in high-frequency (HF: 0,15-0,4 Hz) and low-frequency (LF: 0,04-0,15 Hz) ranges was calculated as well ..."
 
Vol 4, No 3 (2008) COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov, E. V. Malichenko, E. E. Kazantseva
"... with enalapril (р=0,04). Brain natriuretic peptide and von Willebrand factor levels decreased more significantly ..."
 
Vol 12, No 5 (2016) Endothelium Protective Function of Statins in Men and Women with Coronary Atherosclerosis Abstract  similar documents
M. V. Klimushina, N. G. Gumanova, A. Ju. Gorshkov, N. E. Gavrilova, V. A. Metel'skaja, S. A. Boytsov
"... =0.04). Serum endothelin level was 1.8 times lower in men who received statins, compared with men ..."
 
Vol 13, No 3 (2017) EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS Abstract  similar documents
Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, O. I. Lukina
"... in the sacubitril/valsartan group on Day 1 after 6 hours (50%, p=0.004) and subsequent-samples up to 12 hours ..."
 
Vol 13, No 6 (2017) RISK FACTORS OF ARTERIAL HYPERTENSION IN ORGANIZED COHORT OF MALE EMPLOYEES OF THE MACHINE BUILDING PLANT Abstract  similar documents
A. N. Britov, S. A. Tjupaeva, N. A. Eliseeva, A. N. Meshkov, A. D. Deev
"... .3%, respectively; p<0.04), that appears to be evidence of early organ disorders. OF were found more often ..."
 
Vol 14, No 2 (2018) NEPHROPROTECTIVE EFFECTS OF LISINOPRIL IN THE THERAPY OF HYPERTENSIVE PATIENTS WITH OBESITY Abstract  similar documents
S. G. Shulkina, Е. N. Smirnova
"... .3; 60.0] ng/ml (р=0.04) and IL-18 – from 0.33 [0.18; 0.41] to 0.21 [0.14; 0.43] pg/ml (р=0.04). Greater ..."
 
Vol 16, No 4 (2020) Prevalence and Characteristics of Blood Pressure Phenotypes in Patients with Hypertension and Chronic Respiratory Diseases (Study of Ambulatory Practice Data of a Cardiologist) Abstract  similar documents
A. S. Kurekhyan, M. I. Smirnova, V. M. Gorbunov, Ya. N. Koshelyaevskaya, A. D. Deev, M. M. Loukianov
"... cholesterol (b=0.350, p=0.043), degree of nighttime diastolic BP decrease (for 13.1-18.0% b=-2.130, p=0.004 ..."
 
Vol 15, No 3 (2019) Disorders of the Cardiovascular System in Patients with Chronic Viral Hepatitis Abstract  similar documents
M. V. Chistyakova, A. V. Govorin, Yu. V. Parkhomenko
"... of the left ventricle lateral wall, on the mitral valve fibrous ring, in the basal segment ..."
 
Vol 13, No 5 (2017) RATIONAL PHARMACOTHERAPY IN CARDIOLOGY: FROM ROUTINE CONTROL TO EFFECTIVE MANAGEMENT Abstract  similar documents
N. А. Nikolayev, Y. P. Skirdenko, S. S. Bunova, A. V. Ershov
"... ; p=0.002 at the 150th week; p=0.004 at the 200th week). By the end of the study in the patient ..."
 
Vol 6, No 3 (2010) CLINICAL SIGNIFICANCE OF ANEMIC SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
V. N. Larina, B. Ya. Bart, V. G. Larin
"... ,041), had diabetes more often (p=0,004, χ2=8,01) in comparison with non anemic patients. Deficiency of iron ..."
 
Vol 7, No 5 (2011) HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko
"... ) as compared to the control group (RR 0.09; 95%CI 0.01-0.9; p=0.04). Conclusion. Treatment with FA, B and B ..."
 
Vol 6, No 5 (2010) INTERRELATION BETWEEN PERSISTENT NECROSIS OF CARDIOMYOCYTES AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  PDF (Eng)  similar documents
E. N. Golovenko, D. A. Napalkov, V. A. Sulimov
"... . Mean TrI and myoglobin concentrations equaled 0.04 [0.02; 0.06] ng/ml and 62.95 [35.86; 77.28] μg/l ..."
 
Vol 8, No 2 (2012) SYNCOPE IN NON-MASSIVE PULMONARY EMBOLISM AS A PREDICTOR OF HIGH-RISK MORTALITY Abstract  similar documents
E. A. Kurakina, D. V. Duplyakov, S. M. Khokhlunov, G. S. Kozupitsa
"... 14.2% in groups 1 and 2, respectively (p=0.004). High risk of death was defined 3 times more often ..."
 
Vol 5, No 6 (2009) COMPARATIVE EFFICACY OF AMIODARONE AND BISOPROLOL IN TREATMENT OF VENTRICULAR PREMATURE BEATS IN PATIENTS WITH METABOLIC SYNDROME Abstract  similar documents
V. M. Provotorov, M. L. Gluhovsky
"... because of antiarrhythmic effect loss was also revealed (20.0% vs 46.1%, p=0.004). A number of patients ..."
 
Vol 15, No 3 (2019) Mammographic Screening as a Tool for Cardiovascular Risk Assessing. Part 2. Association of Breast Arterial Calcification and Cardiovascular Diseases Abstract  similar documents
E. V. Bochkareva, I. V. Kim, E. K. Butina, I. D. Stulin, S. A. Trukhanov, B. A. Rudenko, S. A. Boytsov, O. M. Drapkina
"... with cerebrovascular diseases and a 1.4-fold increase in the risk of ischemic stroke (p=0.004), atheromatosis ..."
 
Vol 12, No 6 (2016) EFFECT OF AMLODIPINE ON CIRCADIAN RHYTHM OF BLOOD PRESSURE IN HYPERTENSIVE FEMALE PATIENTS WITH DIFFERENT PSYCHO-EMOTIONAL BACKGROUND Abstract  similar documents
V. R. Veber, M. P. Rubanova, S. V. Zhmailova, P. M. Gubskaya, A. I. Vinogradov
"... and from 38.5±10.2 to 95.3±14.7 (p=0.004) in the Group 2. Be- sides increase in load by reduced SBP during ..."
 
Vol 12, No 6 (2016) EFFICIENCY OF INFLUENZA VACCINATION IN PATIENTS WITH CIRCULATORY SYSTEM DISEASES UNDER DISPENSARY OBSERVATION IN OUTPATIENT CLINICS: PROSPECTIVE FOLLOW-UP MONITORING DATA Abstract  similar documents
S. A. Boytsov, M. M. Loukianov, E. V. Platonova, V. M. Gorbunov, S. V. Romanchuk, O. A. Nazarova, O. A. Belova, E. A. Kravtsova, P. Ya. Dovgalevsky, N. V. Furman, A. A. Mironova, P. V. Dolotovskaya, A. V. Nekrasov, N. G. Puchkova, M. A. Abramova, E. N. Belova, V. G. Klyashtorny, A. D. Deev
"... -vaccinated group (28 and 442; р<0.0001). The vaccinated group had fewer CSD worsening cases per patient (p=0.04 ..."
 
Vol 9, No 6 (2013) THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION) Abstract  similar documents
V. A. Sulimov
"... primary PCI group (1.0% vs 0.2%, p=0.04; after correction protocol and dose reduction by half ..."
 
Vol 11, No 5 (2015) Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease Abstract  similar documents
O. A. Rubanenko
"... .5 pg/ml vs 24.1±14.8 pg/ml, р=0.03; 63.7±54.8 pg/ml vs 50.7±40.8 pg/ml, р=0.04, respectively ..."
 
Vol 16, No 4 (2020) Changes in Arterial Wall Stiffness in Patients with Obesity and Paroxysmal Form of Atrial Fibrillation Abstract  PDF (Eng)  similar documents
V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, K. K. Osadchiy, R. G. Gataulin, K. A. Oganesyan, N. V. Lobova, Z. B. Jafarova
"... circumference to hip circumference (WC/HC) ratio and CAVI index (r=0.455, p=0.004); WC/height ratio and CAVI ..."
 
Vol 13, No 5 (2017) INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION Abstract  similar documents
E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash
"... with the ticagrelor group (p=0.04 and p=0.01, respectively). Conclusion. When clopidogrel is replaced with ticagrelor ..."
 
Vol 13, No 5 (2017) COMORBIDITIES IN PATIENTS WITH ISCHEMIC HEART DISEASE: GENDER DIFFERENCES Abstract  similar documents
A. N. Sumin, E. V. Korok, A. V. Shcheglova, O. L. Barbarash
"... .9% of women and 7.4% of men (p=0.031), while the history of MI was more often found in male patients (p=0.004 ..."
 
Vol 13, No 6 (2017) FACTORS INFLUENCING ON THE MORTALITY IN PATIENTS WITH OBLITERATING DISEASES OF LOWER LIMB ARTERIES Abstract  similar documents
A. N. Sumin, M. A. Kosova, Ju. D. Medvedeva, A. V. Shcheglova, O. I. Rajh, S. A. Makarov, G. V. Artamonova, L. S. Barbarash
"... .031), atherosclerosis of two or more arterial basins ≥50% (OR 3.43, 95% CI 3.46-5.52; p=0.004), the presence ..."
 
Vol 7, No 4 (2011) PROTHROMBOTIC POLYMORPHISMS AND LONG-TERM PROGNOSIS OF PATIENTS WITH STABLE ISCHEMIC HEART DISEASE Abstract  similar documents
A. L. Komarov, O. O. Shahmatova, D. V. Rebrikov, D. Yu. Trophimov, T. I. Kotkina, T. A. Ilyushenko, A. D. Deev, E. P. Panchenko
"... .63 times (95% CI 1.2-2.3, р=0.006) and 1.37 times (95% CI 1.001-1.89, р=0.04), respectively. Such genetic ..."
 
Vol 6, No 6 (2010) HEART REMODELING AT DIFFERENT STAGES OF CHRONIC HEART FAILURE IN PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND DILATED CARDIOMYOPATHY Abstract  similar documents
V. V. Mazur, A. M. Kalinkin, E. S. Mazur
"... at any CHF stage in PICS patients was significantly higher than this in DCM patients (1.48±0.04 and 1 ..."
 
Vol 15, No 3 (2019) Vascular Remodeling Markers in Patients with Essential Arterial Hypertension Depending on Presence of Type 2 Diabetes Mellitus Abstract  similar documents
Yu. A. Danilogorskaya, E. A. Zheleznykh, E. A. Privalova, Yu. N. Belenkov, A. A. Shchendrigina, M. V. Kozhevnikova, G. A. Shakaryants, V. Y. Zektser, A. S. Lishuta, I. S. Ilgisonis
"... (11.15 [10.05; 12.35] vs 10.15 [8.83; 11.83] m/s; p=0.04) were found as well as significantly lower (p ..."
 
Vol 15, No 5 (2019) Left Atrial Phasic Function in Patients with Hypertension and Recurrent Atrial Fibrillation: Gender Differences of the Relationship with Diastolic Dysfunction and Central Aortic Pressure Abstract  similar documents
E. V. Kokhan, E. M. Ozova, V. A. Romanova, G. K. Kiyakbaev, Zh. D. Kobalava
"... ejection fraction was higher in women (31 [21;42] vs 24 [19;31]%; p=0.04), whereas passive one – in men (12 ..."
 
Vol 10, No 5 (2014) OUTPATIENT REGISTRY OF CARDIOVASCULAR DISEASES (RECVASA): PROSPECTIVE FOLLOW-UP DATA, ESTIMATION OF RISKS AND OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
"... was significantly higher(OR=2.88, р=0.0001). Permanent AF significantly increased the risk of stroke (OR=2.07, р=0.04 ..."
 
Vol 10, No 3 (2014) THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) Abstract  similar documents
M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev
"... .824, p=0.004] and RAAS inhibitors [OR=0.710; CI=0.512-0.986, p=0.040] prior to the development of acute ..."
 
Vol 8, No 1 (2012) GENDER DISTINCTIONS OF MICROALBUMINURIA AND ITS RELATION TO INTRARENAL HEMODYNAMIC AND LEPTIN LEVEL IN ARTERIAL HYPERTENSION Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, J. N. Rodionova
"... in females with MAU was higher than this in female patients without MAU: 103.5±38.7 vs 76.7±46.4 ng/ml (p=0.04 ..."
 
Vol 16, No 3 (2020) A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study Abstract  similar documents
N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey
"... of the study (7.9%, 9.1% and 20.5% respectively; p=0.04 for the latter). The thromboxane B2 level by the 3rd ..."
 
Vol 16, No 2 (2020) The Effect of Pharmacological Preconditioning with Nicorandil before Elective Coronary Stenting on the Long-Term Prognosis of Patients with Stable Coronary Artery Disease Abstract  similar documents
G. N. Soboleva, R. V. Gostishchev, A. N. Rogoza, T. I. Kotkina, A. N. Samko, Yu. A. Karpov
"... with cutting value 389.8 pg/ml, AUC=0.641 (p=0.04). Сonclusion. Peroral nicorandil 30 mg/day 2 days before PCI ..."
 
Vol 16, No 4 (2020) Optimization of a Comprehensive Prehabilitation Program for Patients with Stable Coronary Artery Disease Undergoing Elective Coronary Artery Bypass Grafting Abstract  PDF (Eng)  similar documents
Yu. A. Argunova, T. N. Zvereva, S. A. Pomeshkina, A. V. Ivanova, O. M. Polikutina, O. V. Gruzdeva, V. V. Kashtalap, O. L. Barbarash
"... in the control group (p=0.04). Group 1 patients reported longer distance covered in 6MWT than Group 2 patients ..."
 
Vol 11, No 4 (2015) EFFECT OF «TREAT-TO-TARGET» ANTIRHEUMATIC THERAPY ON DIASTOLIC DYSFUNCTION OF THE LEFT AND RIGHT VENTRICLES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING 18 MONTHS OF OBSERVATION Abstract  similar documents
I. G. Kirillova, D. S. Novikova, T. V. Popkova, Yu. N. Gorbunova, E. I. Markelova, Yu. O. Korsakova, O. A. Fomicheva, A. V. Volkov, E. L. Luchikhina, N. V. Demidova, K. A. Kasumova, S. A. Vladimirov, M. A. Kanonirova, G. L. Lukina, A. A. Novikov, E. N. Aleksandrova, D. E. Karateev, E. L. Nasonov
"... with the improved LV diastolic function [E/A LV and ΔESR (r=-0,3; p<0,04), E/A LV and CRP (r=-0,2; p<0.05), A LV ..."
 
Vol 15, No 6 (2019) Seasonal Indicators of Blood Pressure, Data of Asthma Control Questionnaires and Quality of Life in Hypertensive Patients with Bronchial Asthma Abstract  similar documents
G. F. Andreeva, M. I. Smirnova, V. M. Gorbunov, A. S. Kurekhyan, Ya. N. Koshelyaevskaya
"... ones, and winter daytime systolic BP values (p<0.05) and clinical diastolic BP (p=0.004) – higher than ..."
 
Vol 16, No 2 (2020) LIS-3 Acute Coronary Syndrome Registry: Changes in Clinical and Demographic Characteristics and Tactics of Prehospital and Hospital Treatment of Surviving Patients After Acute Coronary Syndrome Over a 4-Year Period Abstract  similar documents
S. Yu. Martsevich, A. V. Zagrebelnyy, N. P. Zolotareva, N. P. Kutishenko, Yu. V. Lukina, M. L. Ginzburg, D. A. Startsev, S. V. Blagodatskikh
"... significantly (39.4% and 22.4%, respectively, p=0.004), however, the incidence of atrial fibrillation, history ..."
 
Vol 16, No 2 (2020) Risk Factors, Clinical Features of the Course of Myocardial Infarction and Treatment of Young Patients Based on Two Hospital Registries Abstract  similar documents
O. L. Barbarash, D. Yu. Sedykh, I. S. Bykova, V. V. Kashtalap, A. D. Erlich
"... were more likely to have STEMI (p=0.032), they were more likely to have stenting (p=0.004), they were ..."
 
Vol 16, No 5 (2020) Comparative Characteristics of Patients with Cerebral Stroke and Myocardial Infarction in Outpatient Practice: Structure of Comorbidity, Risk Factors, Drug Treatment and Outcomes Abstract  similar documents
A. N. Vorobyev, K. G. Pereverzeva, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, E. Yu. Okshina, O. M. Drapkina
"... , as compared to the REGATA registry, there was a higher mortality rate (22.1% vs 17.0%; p=0.04), moreover ..."
 
Online First Multivariable Analysis of Primary Care Physician Adherence to Guideline-recommended Pharmacotherapy of Stable Coronary Artery Disease Abstract  similar documents
S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebniova
"... (66,4 vs. 53,6%; p=0,004), arterial hypertension (93,3 vs. 79,7%; p<0,001) and dyslipidemia (21,4 vs ..."
 
Vol 9, No 2 (2013) A META-ANALYSIS REPORTING EFFECTS OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTSWITHOUT HEART FAILURE Abstract  similar documents
G. Savarese, P. Costanzo, J.G.F. Cleland, E. Vassallo, D. Ruggiero, G. Rosano, P. Perrone-Filardi
"... ,928], р<0,004), смерти от всех причин (ОШ: 0,908 [95% ДИ 0,845-0,975], р=0,008), впервые возникшей СН (OШ ..."
 
Vol 13, No 6 (2017) ASSESSMENT OF ADHERENCE TO TREATMENT AND FACTORS AFFECTING IT IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE DURING THERAPY WITH NICORANDIL Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, A. V. Akimova, V. P. Voronina, O. V. Lerman, O. V. Gaisenok, T. A. Gomova, A. V. Ezhov, A. D. Kuimov, R. A. Libis, G. V. Matyushin, T. N. Mitroshina, G. I. Nechaeva, I. I. Reznik, V. V. Skibitsky, L. A. Sokolova, A. I. Chesnikova, N. V. Dobrynina, S. S. Yakushin
"... recommendations than patients, not visiting the treating physician (p=0.004). Сonclusion. The levels of overall ..."
 
Vol 15, No 6 (2019) Outpatient Registry REGION: Prospective Follow-up Data and Outcomes in Patients After Acute Cerebrovascular Accident Abstract  similar documents
M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, K. G. Pereverzeva, E. Yu. Okshina, A. V. Zagrebelnyy, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina
"... outcomes were from CV causes, respectively; р=0.04). The higher risk of death was associated ..."
 
Vol 16, No 2 (2020) Drug Correction of Vascular Remodeling in Patients with Hypertension: Results of 52-Week Prospective Study ARTERIA-AG Abstract  similar documents
O. V. Fedorishina, K. V. Protasov, A. M. Torunova
"... significantly. AIx decreased from 36.5 (24;41)% to 25.0 (15;36)% (p=0.04) in the 1st group and from 36.0 (30 ..."
 
Vol 16, No 6 (2020) Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries) Abstract  similar documents
M. M. Loukianov, E. Yu. Andreenko, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, E. Yu. Okshina, V. V. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, V. G. Klyashtorny, E. V. Kudryashov, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina
"... prescription in women was associated with a lower risk of ACVA (if adjusted for age: RR=0.54; p=0.04 ..."
 
1 - 91 of 91 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)